Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Ital J Pediatr ; 42(1): 65, 2016 Jul 13.
Article in English | MEDLINE | ID: mdl-27411491

ABSTRACT

BACKGROUND: Women in many countries are advised to use folic acid supplements before and early during pregnancy to reduce the risk of neural tube defects in their infants. This study aimed to update the prevalence and to identify possible determinants of preconception folic acid supplement use in Italian women. METHODS: The study was based on cross-sectional data from seven maternity clinics located in six Italian regions from January to June, 2012. Data on maternal characteristics and supplement use were collected for 2,189 women using a self-administered questionnaire. RESULTS: Preconception folic acid use was reported by 23.5 % (n = 515) of the participants. Of these, 479 (93 %) women had taken folic acid supplements on a daily basis as recommended by the health authorities. Women who both had intended their pregnancy and had requested a preconception health visit to a doctor/gynecologist were substantially more likely than the reference group to initiate folic acid supplementation before their pregnancy (48.6 versus 4.8 %). Preconception folic acid use was also associated with higher maternal age, higher education, marriage/cohabitation, lower parity, infertility treatments, and chronic disease. CONCLUSIONS: Data from seven maternity clinics located in six Italian regions indicate that preconception folic acid supplement use in many Italian women is low. Women who do not plan their pregnancy or do not request a preconception health visit to their doctor have among the lowest prevalence of preconception folic acid use. Improving folate status in these and other supplemental non-users may have important disease preventive effects.


Subject(s)
Folic Acid/administration & dosage , Neural Tube Defects/prevention & control , Preconception Care , Adult , Cross-Sectional Studies , Dietary Supplements , Female , Humans , Italy , Prevalence , Surveys and Questionnaires
2.
Ital J Pediatr ; 40: 91, 2014 Nov 23.
Article in English | MEDLINE | ID: mdl-25416843

ABSTRACT

OBJECTIVES: Adequate preconception maternal health care is essential to reduce the risk of unwanted pregnancy outcomes and complications. Still, many women are exposed to a number of unhealthy risk factors both before and early in pregnancy. This study aimed to estimate the prevalence of a number of important preconception risk factors using data from a recent multicenter study in Italy. METHODS: The study was based on cross-sectional data from seven maternity clinics located in six different regions in Italy during the period January - June, 2012. Data on maternal preconception risk factors and characteristics were collected from 1,892 women who delivered healthy children and 320 women who were pregnant in the first trimester. RESULTS: About 97% of the women (n =2,212) were exposed to one or more preconception risk factors. The overall prevalence of the most essential maternal risk factors was as follows: 41% had a age ≥35 years, 36% mistimed or did not intend their pregnancy, 58% did not request a preconception health visit to their doctor, 76% did not use folic acid supplements before pregnancy, 26% smoked at the last menstrual period, 19% had a body mass index ≥25 kg/m2 before pregnancy, and 10% suffered from pregestational chronic diseases. The prevalence of certain variables varied between the maternity clinics. CONCLUSIONS: Many Italian women are exposed to a number of preconception risk factors that have been associated with adverse pregnancy complications and outcomes. More effective intervention programs to improve preconception health in Italian women are strongly needed.


Subject(s)
Health Status , Maternal Behavior , Adolescent , Adult , Ambulatory Care Facilities , Body Mass Index , Chronic Disease/epidemiology , Cross-Sectional Studies , Female , Folic Acid/therapeutic use , Humans , Italy/epidemiology , Middle Aged , Preconception Care/statistics & numerical data , Pregnancy , Pregnancy, Unplanned , Risk Factors , Smoking/epidemiology , Surveys and Questionnaires , Vitamin B Complex/therapeutic use , Young Adult
3.
Med Sci Monit ; 16(10): CS124-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20885356

ABSTRACT

BACKGROUND: In the last decade, body piercing has gained strongly in popularity. There are a few reports in the literature regarding infective endocarditis after body piercing. CASE REPORT: The case of an 18-year-old girl with heart failure and a six-month history of recurring fever is presented. Clinical and laboratory evaluation led to the diagnose of infective endocarditis due to Gemella morbillorum. Oral piercing was recognized to be the cause of bacteremia. Fourteen cases of infective endocarditis related to body piercing were found in the literature and the clinical, etiologic, pathogenic, and preventive aspects of this topic are presented. CONCLUSIONS: Infective endocarditis may be a complication of body piercing and has been observed in patients with heart lesions as well as in previous healthy people. Infective endocarditis can follow body piercing involving either mucous membranes or the skin. This patient is the first case of Gemella morbillorum endocarditis after body piercing reported in the literature. Careful observation for infection at the site of piercing and its treatment as well as professional training for operators seem to be the most effective way to minimize the risk of infective endocarditis after body piercing.


Subject(s)
Body Piercing/adverse effects , Endocarditis, Bacterial/etiology , Gemella , Gram-Positive Bacterial Infections/etiology , Adolescent , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/microbiology , Female , Heart Failure/etiology , Humans , Mitral Valve Insufficiency/etiology
4.
Clin Cardiol ; 32(11): E71-4, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19816985

ABSTRACT

Transcatheter closure is the preferred method of treatment of patent ductus arteriosus (PDA). Detachable coils are widely used to close small ducts, while the Amplatzer duct occluder (ADO) is generally employed for moderate or large ducts. Recently a new device, the Amplatzer duct occluder II (ADO II), a nitinol flexible mesh, with a symmetrical design to provide high conformability for treatment of all types of PDA, has received the European Community mark approval. We report on one of the first experience, four cases (1 male, 3 female, age ranging from six months to seven years old) with different type and size of PDA treated with the new device. The use of this new Amplatzer duct occluder in our experience has the advantage of ease and safety of placement, conformability, stability, low profile catheters, adaptability for long ducts as in type E.


Subject(s)
Cardiac Catheterization/instrumentation , Ductus Arteriosus, Patent/therapy , Septal Occluder Device , Alloys , Cardiac Catheterization/adverse effects , Child , Child, Preschool , Coronary Angiography , Ductus Arteriosus, Patent/diagnostic imaging , Equipment Design , Female , Humans , Infant , Male , Treatment Outcome
6.
Acta Biomed ; 80(1): 36-41, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19705618

ABSTRACT

BACKGROUND AND AIM OF THE WORK: Syncope occurs frequently in childhood and adolescence. It generally is benign, but may be a sign of pathology. The purpose of this study is to determine the incidence of syncope in children and adolescents in the Parma area, analyse the frequency of syncope due to cardiac, neurological or metabolic diseases, to identify a diagnostic procedure based on careful review, clinical features, and results of investigations. METHODS: The records of 156 children (age 1 to 18 years, mean age 10.5), who were referred to the Paediatric Department for syncope were reviewed. RESULTS: The incidence of syncope in the paediatric population of Parma during a 2-year period (2005-2006) resulted in 86.5/100.000 per year. The cause of syncope was discovered in 154/156 cases. Cardiovascular syncope was diagnosed in 121/156 cases (77.5%). Neurological syncope was diagnosed in 31/156 cases (20%), while metabolic syncope was diagnosed in 2/156 cases (1.25%). The most frequent type was the (benign) neurocardiogenic syncope, but 3 cases were due to arrhythmia, 9 cases were due to epilepsy, 1 case was due to subarachnoid hemorrage and 2 cases were due to hypoglicemia. CONCLUSIONS: Syncope frequently requires medical examination or admission to paediatric departments and, in the majority of cases, does not subtend serious diseases. Nevertheless, syncope always requires a complete medical evaluation in order to exclude underlying pathology. An electrocardiogram must complete the initial evaluation of all patients with syncope. Other investigations are required if clinical data and the ECG do not provide an etiological explanation of the episode.


Subject(s)
Brain Diseases/complications , Cardiovascular Diseases/complications , Hypoglycemia/complications , Mental Disorders/complications , Syncope/epidemiology , Adolescent , Brain Diseases/diagnosis , Brain Diseases/therapy , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/therapy , Child , Child, Preschool , Cohort Studies , Emergency Service, Hospital , Female , Humans , Hypoglycemia/diagnosis , Hypoglycemia/therapy , Incidence , Infant , Italy , Male , Mental Disorders/diagnosis , Mental Disorders/therapy , Retrospective Studies , Syncope/diagnosis , Syncope/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...